Bibliografía

Ayra M, Díaz O. Productos de la glucosilación avanzada y diabetes mellitus. Rev Cubana End 1999; 10 (1): 57-64. Trabajos de revisión Instituto Nacional de Endocrinología.
http://es.scribd.com/doc/55863203/Productos-de-La-Glucosilaci-n-Avanzada-y-Diabetes-Mellitus

Referencias

  1. Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications.
  2. Beisswenger P, Moore L, Curphy T. Relation of glycemic control collagen-linked advanced glycation end products in type I diabetes.
  3. Gagliardino J, Rebolledo O. Glucosilación no enzimática de proteínas y complicaciones crónicas de la diabetes.
  4. Mott J, Khalifah R, Nagase H, Shield C, Hudson J, Hudson B. Nonenzymatic glycation of type IV collagen and matrix metalloproteinase susceptibility.
  5. Kapurtniotu A, Bernhagen J, Greenfield N, Al-Abed Y, Teichberg S, Frank R. Contribution of advanced glycosilation to the amyloidogenicity of islet amyloid polypeptide.
  6. Bucala R, Makita Z, Koschinsky T, Cerami A, Vlassara H. Lipid advanced glycosylation.
  7. Krantz S, Michalke R, Brandt R, Salazar R, Hartmann K. Evidence for binding of in vitro glycated low-density lipoproteins by fructosillysine-specific sites on macrophages and U937 monocytes-like cells.
  8. Bucala R, Makita Z, Vega G. Modification oj LDL by advanced glycosylation products contributes to the dyslipidemia of diabetes and renal insuficiency.
  9. Vlassara H. Advanced glycation end products and atherosclerosis.
  10. Miyata T, Ueda Y, Horie K, Nangaku M, Tanaka S, Van Yperselle C. Renal catabolism of advanced glycation end products: the fate of pentosidine.
  11. Lefer A, Lefer D. The role of nitric oxide and cell adhesion molecules on the microcirculation in ischaemia-reperfusion.
  12. Picard S, Parathasarathy S, Fruebis J, Witzim JL. Aminoguanidine inhibits oxidative modification of low density lipoprotein and the subsequent increase in uptake by macrophage scavenger receptors.
  13. Traverso N, Menini S, Cottalasso D, Odetti P, Marinari U, Adelaide-Pronzato M. Mutual interaction between glycation and oxidation during non-enzymatic protein modification.
  14. Korchinski T, Jiang He C, Mitsuahashi T, Bucala R, Liu C, Bueting C, Heimann K, Vlassara H. Orally absorbed reactive glycation products (glycotoxins): an environmental risk factor in diabetic nephropathy.
  15. Cerami C, Found H, Nicholl I, Mitsuhashi T, Giordano D, Vanpatten S, et al. Tobacco smoke is a source of toxic reactive glycation products.